Association of Nuclear Medicine and Molecular Imaging (ANMMI)
Objective
Our vision is to optimize and advance science and education in nuclear medicine and molecular imaging for the benefit of public health. The goal of the current interest group is to be a platform for the dissemination and discussion of the latest results in the field of nuclear medicine including multimodality imaging and related subjects. It fosters and co-ordinates the mutual exchange of knowledge relating to the diagnosis, treatment and prevention of diseases through the use of unsealed radioactive substances and the properties of stable nuclides in medicine.
Definition
It is widely understood that molecular imaging is an emerging frontier of biomedical research with important potential ramifications for medical diagnosis and therapy. Techniques of molecular imaging are revealing new knowledge about normal and abnormal structure and function at the cellular and molecular levels, and are providing promising mechanisms for guiding the delivery of new therapies to aberrant cells and tissues.
Paper
- Vasculitis of ascending aorta detected on FDG PET/CT in a patient with fever of unknown origin
-
NULL
- Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma: A Systematic Review and a Meta-Analysis
-
NULL
- 18F-FDG PET/CT findings in a possible MELAS syndrome: A case study
-
NULL
- Unusual false-positive results of whole-body 131I scintigraphy: Four different case scenarios
-
NULL
- Absent radiotracer uptake in thyroid gland in parathyroid scintigraphy with 99mTc-MIBI: A case report
-
NULL
- Multiple myeloma in a patient with suspected hyperparathyroidism
-
NULL
- 68Ga-DOTATATE PET/CT Compared with 131I-MIBG SPECT/CT in the Evaluation of Neural Crest Tumors
-
NULL
- Imaging review of ocular and optic nerve trauma
-
NULL
- Predictors of success of the ablative/therapeutic radioiodine (131I) in differentiated thyroid cancer
-
NULL
- The effects of monosodium glutamate on PSMA radiotracer uptake in men with recurrent prostate cancer: a prospective, randomized, double-blind, placebo-controlled intra-individual imaging study
-
NULL
- 177Lu-EDTMP for Metastatic Bone Pain Palliation: A Systematic Review and Meta-analysis
-
NULL
- A Prospective Study on [68Ga]-PSMA PET/CT Imaging in Newly Diagnosed Intermediate- and High-Risk Prostate Cancer
-
NULL
- Factors predicting biochemical response and survival benefits following radioligand therapy with [177Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review
-
NULL
- 17: Assessment of Salvage Radiation Therapy Volume Based on 18F-DCFPyL PSMA PET/CT in Patients with Biochemical Recurrence After Radical Prostatectomy
-
NULL
- Prognostic value of 2-[18F]FDG PET-CT in metastatic melanoma patients receiving immunotherapy
-
NULL
- An Evolution of Reporting: Identifying the Missing Link
-
NULL
- PSA-Stratified Performance of [18F]DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer Patients under Androgen Deprivation Therapy
-
NULL
- Intra-individual comparison of 18F-sodium fluoride PET–CT and 99mTc bone scintigraphy with SPECT in patients with prostate cancer or breast cancer at high risk for skeletal metastases (MITNEC-A1): a multicentre, phase 3 trial
-
NULL
- 18F-NaF PET–CT versus 99mTc SPECT in bone metastasis assessment – Authors' reply
-
NULL
- Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy.
-
NULL
- Automatic segmentation of prostate cancer metastases in PSMA PET/CT images using deep neural networks with weighted batch-wise dice loss
-
NULL
- Bipolar Androgen Therapy: When Excess Fuel Extinguishes the Fire
-
NULL
- PSMA-Hornet: Fully-automated, multi-target segmentation of healthy organs in PSMA PET/CT images
-
NULL
- Bone Metastasis in Prostate Cancer: Bone Scan Versus PET Imaging
-
NULL
- Head-to-Head Comparison of CZT-SPECT and SPECT/CT Myocardial Perfusion Imaging: Interobserver and Intraobserver Agreement and Diagnostic Performance
-
NULL
- Differential privacy preserved federated transfer learning for multi-institutional 68Ga-PET image artefact detection and disentanglement
-
NULL
- Unraveling the Hypocalcemic Response to 177Lu-Prostate-Specific Membrane Antigen Therapy
-
NULL
Oral/Poster presentation
- Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma A Systematic Review and a Meta-Analysis
-
NULL
- The effects of monosodium glutamate on PSMA radiotracer uptake in men with recurrent prostate cancer: a prospective, randomized, double-blind, placebo-controlled intra-individual imaging study.
-
SNMMI 2020 Annual Meeting
- Unsupervised background removal by dual-modality PET/CT guidance: application to PSMA imaging of metastases
-
SNMMI 2021 Annual Meeting
- Automatic lesion detection and segmentation in PSMA PET/CT images using deep neural networks
-
Top Rated Oral Presentation-EANM 2021
- PSA-Stratified Performance of [18F]DCFPyL PET/CT in Biochemically Recurrent Prostate Cancer: Influence of Androgen Deprivation Therapy
-
NULL
- Radioimmunotherapy in Oncology
-
NULL
- 18F-FDG PET/CT Imaging of Infection and Inflammation
-
NULL
- First-in-Human Clinical trial of [18F]AMBF3-TATE for PET imaging of neuroendocrine tumors
-
NULL
- Outcome of patients with biochemical recurrence of prostate cancer after PSMA PET/CT-directed radiotherapy or surgery without systemic therapy
-
NULL
- A prospective multicenter intra-individual comparison of 18F-NaF PET/CT and 99mTc-bone scintigraphy with SPECT for detection of skeletal metastases in high-risk prostate and breast cancer patients
-
NULL
- Observer study-based evaluation of TGAN architecture used to generate oncological PET images
-
NULL
- State-of-the-art object detection algorithms for small lesion detection in PSMA PET: use of rotational maximum intensity projection (MIP) images
-
NULL
- Prospective evaluation of the utility of concurrent 18F-FDG PET/CT and 68Ga-DOTA-TOC imaging in gastroenteropancreatic neuroendocrine neoplasms (GEPNENs): The PETNET study
-
NULL
- Development of theranostic digital twins framework to perform quantitative image analysis of radiopharmaceutical biodistributions
-
NULL
- PET imaging of endogenous markers of T-cell response
-
NULL
- 18F-FDG PET/CT Imaging in Fever of Unknown Origin
-
NULL
- Somatostatin Receptor-Based Molecular Imaging and Therapy in Neuroendocrine Differentiation of Prostate Cancer
-
NULL
- Advanced Deep Learning-based Lesion Detection on Rotational 2D Maximum Intensity Projection (MIP) Images Coupled with Reverse Mapping to the 3D PET Domain
-
NULL
- Pretreatment 18F-FDG PET/CT radiomics predict recurrence in patients treated with radiotherapy for cervical cancer
-
NULL
- Does the timing of somatostatin-analog therapy affect the imaging properties of DOTA-TOC PET?
-
NULL
- 18F-FDG PET/CT: a useful imaging modality that goes beyond tumor staging in the rapidly advancing era of immune checkpoint inhibitors and targeted agents in cutaneous melanoma
-
NULL
Book
- Chapter: Cancer Imaging with Radiolabeled Monoclonal Antibodies
-
NULL
- Book: Nuclear Medicine and Immunology
-
NULL
- Chapter: Introduction on Nuclear Medicine and Immunology
-
NULL
- Chapter: PET Imaging in Clinical Oncology
-
NULL
- Chapter: Autoimmune diseases
-
NULL